Cargando…
The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics
The SARS-CoV-2 virus has spread world-wide since December 2019, killing more than 2.9 million of people. We have adapted a statistical model from the SIR epidemiological models to predict the spread of SARS-CoV-2 in France. Our model is based on several parameters and assumed a 4.2% seroprevalence i...
Autores principales: | Dimeglio, Chloé, Loubes, Jean-Michel, Miedougé, Marcel, Herin, Fabrice, Soulat, Jean-Marc, Izopet, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206100/ https://www.ncbi.nlm.nih.gov/pubmed/34131234 http://dx.doi.org/10.1038/s41598-021-92131-0 |
Ejemplares similares
-
Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France
por: Dimeglio, Chloé, et al.
Publicado: (2021) -
Estimating the impact of public health strategies on the spread of SARS‐CoV‐2: Epidemiological modelling for Toulouse, France
por: Dimeglio, Chloé, et al.
Publicado: (2021) -
Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: A modeling study from Toulouse, France
por: Dimeglio, Chloé, et al.
Publicado: (2021) -
The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France
por: Dimeglio, Chloé, et al.
Publicado: (2020) -
One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection
por: Dimeglio, Chloé, et al.
Publicado: (2021)